Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain

Paterson, 2005, Extended‐spectrum β‐lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005

Bauernfeind, 1987, Novel R‐factor borne β‐lactamase ofEscherichia coli confering resistance to cephalosporins, Infection, 15, 257, 10.1007/BF01644127

Bauernfeind, 1989, Extended broad spectrum β‐lactamase inKlebsiella pneumoniae including resistance to cephamycins, Infection, 17, 316, 10.1007/BF01650718

Jacoby, 2009, AmpC β‐lactamases, Clin Microbiol Rev, 22, 161, 10.1128/CMR.00036-08

Pitout, 2008, Extended‐spectrum β‐lactamase‐producingEnterobacteriaceae: an emerging public‐health concern, Lancet Infect Dis, 8, 159, 10.1016/S1473-3099(08)70041-0

Pitout, 2007, Population‐based laboratory surveillance for AmpC β‐lactamase‐producingEscherichia coli, Calgary, Emerg Infect Dis, 13, 443, 10.3201/eid1303.060447

Sidjabat, 2009, Clinical features and molecular epidemiology of CMY‐type β‐lactamase‐producingEscherichia coli, Clin Infect Dis, 48, 739, 10.1086/597037

Hanson, 2008, Surveillance of community‐based reservoirs reveals the presence of CTX‐M, imported AmpC, and OXA‐30 β‐lactamases in urine isolates ofKlebsiella pneumoniae andEscherichia coli in a U.S. community, Antimicrob Agents Chemother, 52, 3814, 10.1128/AAC.00877-08

Kang, 2004, Bloodstream infections due to extended‐spectrum β‐lactamase‐producingEscherichia coli andKlebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy, Antimicrob Agents Chemother, 48, 4574, 10.1128/AAC.48.12.4574-4581.2004

Rodriguez‐Bano, 2006, Bacteremia due to extended‐spectrum β‐lactamase‐producingEscherichia coli in the CTX‐M era: a new clinical challenge, Clin Infect Dis, 43, 1407, 10.1086/508877

Rodriguez‐Bano, 2008, Community infections caused by extended‐spectrum β‐lactamase‐producingEscherichia coli, Arch Intern Med, 168, 1897, 10.1001/archinte.168.17.1897

Rodriguez‐Bano, 2004, Epidemiology and clinical features of infections caused by extended‐spectrum β‐lactamase‐producingEscherichia coli in nonhospitalized patients, J Clin Microbiol, 42, 1089, 10.1128/JCM.42.3.1089-1094.2004

Carattoli, 2008, Animal reservoirs for extended spectrum β‐lactamase producers, Clin Microbiol Infect, 14, 117, 10.1111/j.1469-0691.2007.01851.x

Clinical and Laboratory Standards Institute, 2006

Perez‐Perez, 2002, Detection of plasmid‐mediated AmpC β‐lactamase genes in clinical isolates by using multiplex PCR, J Clin Microbiol, 40, 2153, 10.1128/JCM.40.6.2153-2162.2002

Horan, 2008, CDC/NHSN surveillance definition of health care‐associated infection and criteria for specific types of infections in the acute care setting, Am J Infect Control, 36, 309, 10.1016/j.ajic.2008.03.002

Friedman, 2002, Health care‐associated bloodstream infections in adults: a reason to change the accepted definition of community‐acquired infections, Ann Intern Med, 137, 791, 10.7326/0003-4819-137-10-200211190-00007

Garcia Dde, 2008, Multiclonal outbreak ofKlebsiella pneumoniae producing extended‐spectrum β‐lactamase CTX‐M‐2 and novel variant CTX‐M‐59 in a neonatal intensive care unit in Brazil, Antimicrob Agents Chemother, 52, 1790, 10.1128/AAC.01440-07

Clermont, 2000, Rapid and simple determination of theEscherichia coli phylogenetic group, Appl Environ Microbiol, 66, 4555, 10.1128/AEM.66.10.4555-4558.2000

Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed‐field gel electrophoresis: criteria for bacterial strain typing, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995

Wiener, 1999, Multiple antibiotic‐resistantKlebsiella andEscherichia coli in nursing homes, JAMA, 281, 517, 10.1001/jama.281.6.517

Trick, 2001, Colonization of skilled‐care facility residents with antimicrobial‐resistant pathogens, J Am Geriatr Soc, 49, 270, 10.1046/j.1532-5415.2001.4930270.x

Rodríguez‐Baño, 2009, Escherichia coli producing SHV‐type extended‐spectrum beta‐lactamase is a significant cause of community‐acquired infection, J Antimicrob Chemother, 63, 781, 10.1093/jac/dkp028

Li, 2007, β‐Lactam resistance and β‐lactamases in bacteria of animal origin, Vet Microbiol, 121, 197, 10.1016/j.vetmic.2007.01.015

Jouini, 2007, Characterization of CTX‐M and SHV extended‐spectrum β‐lactamases and associated resistance genes inEscherichia coli strains of food samples in Tunisia, J Antimicrob Chemother, 60, 1137, 10.1093/jac/dkm316

Mesa, 2006, Extended‐spectrum β‐lactamase‐producingEnterobacteriaceae in different environments (humans, food, animal farms and sewage), J Antimicrob Chemother, 58, 211, 10.1093/jac/dkl211

Jensen, 2006, First description of an oxyimino‐cephalosporin‐resistant, ESBL‐carryingEscherichia coli isolated from meat sold in Denmark, J Antimicrob Chemother, 57, 793, 10.1093/jac/dkl048

Warren, 2008, Imported chicken meat as a potential source of quinolone‐resistantEscherichia coli producing extended‐spectrum β‐lactamases in the UK, J Antimicrob Chemother, 61, 504, 10.1093/jac/dkm517

Johnson, 2007, Antimicrobial drug‐resistantEscherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004, Emerg Infect Dis, 13, 838, 10.3201/eid1306.061576

Johnson, 2009, Molecular analysis ofEscherichia coli from retail meats (2002–2004) from the United States National Antimicrobial Resistance Monitoring System, Clin Infect Dis, 49, 195, 10.1086/599830

Rodríguez‐Baño, 2008, Faecal carriage of extended‐spectrum β‐lactamase‐producingEscherichia coli: prevalence, risk factors, and molecular epidemiology, J Antimicrob Chemother, 62, 1142, 10.1093/jac/dkn293